Tag: OPDP

CHC_FDA-Regulatory Images1

CDER’s Woodcock Says First Amendment Concerns Dampen OPDP Enforcement

CHC_general1

FDA Studying Extent of Risk Information in DTC Print Ads

CHC_offLabel

FDA Finalizing Study of Disclosure Effectiveness in Drug Promotion

CHC_general1

Exhibit Booth and Webpage Misbrand IND, OPDP Says in Enforcement Letter

CHC_FDA-Regulatory Images1

False/Misleading Risk, Efficacy Claims in Online Video Cited in OPDP Enforcement Letter to Pfizer

CHC_DTCadvertisement1

FDA Ramps Up Drug Promotion Research Focus

CHC_FDA-Regulatory Images1

First 2018 OPDP Enforcement Letter Targets Exhibit Booth for Opioid

CHC_general2

OPDP Enforcement Letter Grand Total for 2017: Five

CHC_offLabel

FDA To Study Consumer, HCP Ability to Spot Deceptive Drug Ads